BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 23715894)

  • 1. HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.
    Iannetta M; Bellizzi A; Lo Menzo S; Anzivino E; D'Abramo A; Oliva A; D'Agostino C; d'Ettorre G; Pietropaolo V; Vullo V; Ciardi MR
    J Neurovirol; 2013 Jun; 19(3):274-9. PubMed ID: 23715894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
    Kurmann R; Weisstanner C; Kardas P; Hirsch HH; Wiest R; Lämmle B; Furrer H; Du Pasquier R; Bassetti CL; Sturzenegger M; Krestel H
    J Neurovirol; 2015 Dec; 21(6):694-701. PubMed ID: 25916731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy in Zambia is caused by JC virus with prototype regulatory region.
    Mubanga E; Patel A; Siddiqi OK; Hanson BA; Dang X; Lakhi S; Mulundu G; Bender N; Koralnik IJ
    J Neurovirol; 2019 Aug; 25(4):475-479. PubMed ID: 31028690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the transcriptional control region of JC polyomavirus in cerebrospinal fluid from HIV-negative patients with progressive multifocal leucoencephalopathy.
    Fedele CG; Polo C; Tenorio A; Niubò J; Ciardi MR; Pérez JL
    J Med Virol; 2006 Oct; 78(10):1271-5. PubMed ID: 16927288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JC virus load in cerebrospinal fluid and transcriptional control region rearrangements may predict the clinical course of progressive multifocal leukoencephalopathy.
    Delbue S; Elia F; Carloni C; Tavazzi E; Marchioni E; Carluccio S; Signorini L; Novati S; Maserati R; Ferrante P
    J Cell Physiol; 2012 Oct; 227(10):3511-7. PubMed ID: 22253012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Bossolasco S; Calori G; Moretti F; Boschini A; Bertelli D; Mena M; Gerevini S; Bestetti A; Pedale R; Sala S; Sala S; Lazzarin A; Cinque P
    Clin Infect Dis; 2005 Mar; 40(5):738-44. PubMed ID: 15714422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of JC virus in cerebrospinal fluid from HIV-1 infected patients with progressive multifocal leukoencephalopathy: insights into viral pathogenesis and disease prognosis.
    Marzocchetti A; Sanguinetti M; Giambenedetto SD; Cingolani A; Fadda G; Cauda R; De Luca A
    J Neurovirol; 2007 Aug; 13(4):338-46. PubMed ID: 17849317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
    Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
    J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.
    Fedele CG; Ciardi MR; Delia S; Contreras G; Perez JL; De Oña M; Vidal E; Tenorio A
    J Neurovirol; 2003 Oct; 9(5):551-8. PubMed ID: 13129769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Progressive Multifocal Leukoencephalopathy Lesion Volume With JC Virus Polymerase Chain Reaction Results in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple Sclerosis.
    Wijburg MT; Kleerekooper I; Lissenberg-Witte BI; de Vos M; Warnke C; Uitdehaag BMJ; Barkhof F; Killestein J; Wattjes MP
    JAMA Neurol; 2018 Jul; 75(7):827-833. PubMed ID: 29532061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of JC virus-specific CD4 T-cell responses in preventing progressive multifocal leukoencephalopathy.
    Gasnault J; Kahraman M; de Goër de Herve MG; Durali D; Delfraissy JF; Taoufik Y
    AIDS; 2003 Jul; 17(10):1443-9. PubMed ID: 12824781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.
    Gosert R; Kardas P; Major EO; Hirsch HH
    J Virol; 2010 Oct; 84(20):10448-56. PubMed ID: 20686041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes.
    Clifford DB; Nath A; Cinque P; Brew BJ; Zivadinov R; Gorelik L; Zhao Z; Duda P
    J Neurovirol; 2013 Aug; 19(4):351-8. PubMed ID: 23733308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progressive multifocal leukoencephalopathy with bilateral middle cerebellar peduncle lesions confirmed by repeated CSF-JC virus tests and coexistence of JC virus granule cell neuronopathy. Report of a case].
    Ito D; Yasui K; Hasegawa Y; Nakamichi K; Katsuno M; Takahashi A
    Rinsho Shinkeigaku; 2016 Jul; 56(7):481-5. PubMed ID: 27356732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and Prognostic Value of JC Virus DNA in Plasma in Progressive Multifocal Leukoencephalopathy.
    Ferretti F; Bestetti A; Yiannoutsos CT; Musick BS; Gerevini S; Passeri L; Bossolasco S; Boschini A; Franciotta D; Lazzarin A; Cinque P
    Clin Infect Dis; 2018 Jun; 67(1):65-72. PubMed ID: 29346632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy with mild clinical conditions and detection of archetype-like JC virus in cerebrospinal fluid.
    Iwami K; Nakamichi K; Matsushima M; Nagai A; Shirai S; Nakakubo S; Takahashi-Iwata I; Yamada M; Yabe I
    J Neurovirol; 2021 Dec; 27(6):917-922. PubMed ID: 34550545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy.
    De Luca A; Giancola ML; Ammassari A; Grisetti S; Cingolani A; Paglia MG; Govoni A; Murri R; Testa L; Monforte AD; Antinori A
    AIDS; 2000 Sep; 14(14):F117-21. PubMed ID: 11061646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of a progressive multifocal leukoencephalopathy patient with four different JC virus transcriptional control region rearrangements in cerebrospinal fluid, blood, serum, and urine.
    Delbue S; Sotgiu G; Fumagalli D; Valli M; Borghi E; Mancuso R; Marchioni E; Maserati R; Ferrante P
    J Neurovirol; 2005 Feb; 11(1):51-7. PubMed ID: 15804959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy.
    Koralnik IJ; Boden D; Mai VX; Lord CI; Letvin NL
    Neurology; 1999 Jan; 52(2):253-60. PubMed ID: 9932940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of archetype and rearranged variants of JC virus in multiple tissues from a pediatric PML patient.
    Newman JT; Frisque RJ
    J Med Virol; 1997 Jul; 52(3):243-52. PubMed ID: 9210031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.